Transgene S.a annual revenue
2020
2021
2022
2023
2024
2025
Transgene S.a Revenue Growth & History (TNG)
Transgene S.a reported €7.2M in revenue for fiscal 2025, an increase of 13.49% from the previous fiscal year.
View full Transgene S.a company overviewTransgene S.a annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €7.2M | €857,000 | +13.49% |
| 2024 | 2024-12-31 | €6.4M | −€1.5M | −19.58% |
| 2023 | 2023-12-31 | €7.9M | −€2.4M | −23.63% |
| 2022 | 2022-12-31 | €10.3M | €351,000 | +3.51% |
| 2021 | 2021-12-31 | €10.0M | €7.0M | +235.22% |
| 2020 | 2020-12-31 | €3.0M | — | — |
Transgene S.a revenue growth trends
Over the last five reported fiscal years, revenue grew from €3.0M to €7.2M, a compound annual growth rate of 19.32%.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Transgene S.a source filings ↗Community posts
Transgene reports €92.8 million in liquidity as vaccine development advances
Transgene ($TNG) reported €92.8 million in cash, cash equivalents and other current financial assets at its half-year end, compared with €111.9 million at the start of the year. First-half cash burn increased to €20.3 million from €18.8 mil ...
